Multicenter Study of Magnetic Resonance-guided High Intensity Focused Ultrasound for Pain Palliation of Bone Metastases
Magnetic Resonance-guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases - a Multicenter Study
Sponsor: Philips Healthcare
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Philips Healthcare
Other Bone Metastasis trials with similar outcome
Listed as NCT01586273, this NA trial focuses on Bone Metastasis and remains terminated or withdrawn. Sponsored by Philips Healthcare, it has been updated 7 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
▶ Show 2 earlier versions
-
May 2017 — Jun 2018 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jan 2017 — May 2017 [monthly]
Active Not Recruiting NA
First recorded
Sep 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Philips Healthcare
For direct contact, visit the study record on ClinicalTrials.gov .